1316:
190:
168:
234:
212:
146:
2122:
27:
378:, the migraine drug CVT-427 and rights to the ARCUS pulmonary delivery system. Th ARCUS technology allows for the administration of drugs by inhalation. The FDA-approved drug Inbrija (levodopa inhalation powder) and the clinical-stage drug CVT-427 (zolmitriptan) currently use the ARCUS technology for drug delivery.
406:
of the company from the start was to work on commercialization of academic discoveries. A single therapeutic area focus also has the advantage that physicians prescribing one drug might also prescribe another in Acorda's portfolio; for instance, the company planned to leverage physician access
582:
emeritus), Denise Duca (executive vice president, human resources), Andrew A. Hidman (chief business officer), David
Lawrence (chief, business operations and principal accounting officer), Lauren Sabella (chief commercial officer), Tierney Saccavino (executive vice president, corporate
459:. This was Acorda's flagship product and development of subsequent drug candidates was initially predicated on realized revenue from this drug's sales. In November 2016, the company announced it was discontinuing development of the drug for post-
418:, about half of what was expected going into the offering, which was attributed to general weakness of the IPO market at the time. These funds were supplemented by a private sale of shares later the same year, raising and additional
1021:
590:
As of 2019, founder, president and CEO Cohen would be about 63 years old. Andrew Blight was the CSO in 2007 and would, as of 2019, be about 68 years old, an emeritus in this role. As of 2007, David
Lawrence was the
1039:
1343:
901:
394:. Cohen had previously worked at the tissue engineering firm Advanced Tissue Sciences from 1986 to 1992. Cohen's focus on neurology at Acorda was influenced by his father's being a
1065:
2162:
439:
protection, and announced that it had secured a "stalking horse" bid for all of its assets. As a result of the bankruptcy filing, the company's stock fell approximately 40%.
880:
1129:
1336:
463:
walking difficulties, after a clinical trial failure. In the third quarter of 2019, the company's shares dropped by a significant 65.1% as a result of dalfampridine's
975:
1086:
563:
of Acorda
Therapeutics were: Ron Cohen, Barry Greene, Peder K. Jensen, John P. Kelley, Sandra Panem, Lorin J. Randall, Steven M. Rauscher, and Catherine D. Strader.
2182:
2167:
1265:
479:
approval of
Inbrija (levodopa inhalation powder) for patients with Parkinson's disease. In January 2021, Acorda sold its manufacturing operations for Inbrija to
2152:
1352:
1329:
2147:
326:
Inbrija is administered by inhalation and is indicated for the intermittent treatment of off episodes in patients with
Parkinson's disease currently taking
2157:
1834:
1824:
1814:
1804:
1794:
1784:
1774:
1764:
1754:
863:
2177:
2142:
1155:
726:
432:
From 2019 to 2021 the company's earnings per share (EPS) increased by 4.5% every year. In 2021, the company's revenue was down by 13 percent.
1111:
737:
1202:
543:
antagonist tozadenant. In
November 2017, the company announced discontinuation of research and development of the Phase III
448:
1246:
926:
602:
In 2024, Acorda
Therapeutics went bankrupt with its stock being delisted from the NASDAQ. In its bankruptcy proceedings, a
451:
held the patent for this drug in 2002 when the organization engaged Acorda to conduct a Phase III trial for treatment of
399:
160:
2099:
1087:"Acorda offloads manufacturing operations to Catalent for $ 70M amid latest restructuring to keep the ship afloat"
956:
693:
2172:
1967:
1290:
902:"Shareholders May Be More Conservative With Acorda Therapeutics, Inc.'s (NASDAQ:ACOR) CEO Compensation For Now"
536:
340:
702:
1506:
1725:
700:. Vol. 119, no. 30. White Plains, New York: Gannett. pp. 1C, 10C – via Newspapers.com.
566:
As of
February 14, 2019, the members of the senior management team were: Ron Cohen M.D. (Founder,
476:
2082:
1536:
1002:
567:
599:. Jane Wasman, about 62 in 2019, has held the general counsel role at the company since at least 2007.
2112:
1531:
547:
drug tozadenant. This followed the death of 5 patients enrolled in the tozadenant Phase III trial from
636:
1705:
1675:
1660:
1588:
1573:
1511:
1456:
1022:"The Acorda Therapeutics (NASDAQ:ACOR) Share Price Is Down 91% So Some Shareholders Are Rather Upset"
1176:
2037:
1972:
1680:
1421:
579:
294:
and other neurological disorders. Acorda
Therapeutics manufactures and markets the drugs Inbrija (
1887:
1608:
1598:
1593:
1451:
1391:
1220:
596:
592:
571:
411:
112:
1321:
1066:"New Parkinson's Drug Comes to Market after Early Investment from The Michael J. Fox Foundation"
1992:
1962:
1912:
1867:
1715:
1406:
1266:"After $ 185M asset buy, Merz Therapeutics plots US workforce expansion as CEO eyes more deals"
841:
820:
799:
544:
540:
287:
2067:
1872:
1690:
1655:
1501:
1481:
575:
436:
976:"Acorda Therapeutics plummets as much as 13% on failed trial, discontinued drug development"
2027:
2002:
1952:
1947:
1927:
1877:
1810:
1800:
1670:
1645:
1553:
1548:
1516:
1446:
1416:
611:
603:
8:
2052:
2017:
2007:
1932:
1917:
1640:
1635:
1366:
614:
was arranged. The deal included Merz's purchase of
Inbrija and Ampyra for $ 185 million.
391:
1315:
1977:
1790:
1760:
1710:
1476:
1461:
560:
504:
464:
456:
426:
358:
327:
291:
842:"rHIgM22 Remyelinating Monoclonal Antibody for Potential Multiple Sclerosis Treatment"
775:
1957:
1922:
1411:
1284:
512:
508:
283:
95:
1040:"Acorda Therapeutics Announces FDA Approval of INBRIJA (levodopa inhalation powder)"
2126:
1685:
1623:
1603:
1558:
1543:
1486:
528:
286:. The company develops therapies that improve neurological function in people with
226:
2032:
1942:
1937:
1578:
1526:
1496:
751:
584:
548:
312:
299:
126:
1862:
1568:
403:
37:
26:
2136:
2042:
1840:
1742:
1650:
279:
55:
1158:. New York, New York: The Michael J. Fox Foundation for Parkinson's Research
1068:. New York, New York: The Michael J. Fox Foundation for Parkinson's Research
1820:
516:
347:
2012:
1695:
1563:
607:
395:
50:
2072:
1700:
1431:
492:
452:
182:
527:
In January 2016, the company acquired Finnish pharmaceutical company,
425:
As of 2007, twelve years after incorporation, the company had not yet
2022:
1892:
1665:
1630:
1491:
1466:
963:. Salisbury, Maryland: Gannett. p. 9 – via Newspapers.com.
551:
and associated severe adverse events possibly related to tozadenant.
500:
387:
1902:
1897:
1780:
1770:
1441:
480:
351:
511:
forms of this drug, with emphasis on the capsule form as this has
2057:
1907:
1830:
1750:
1720:
1618:
1583:
1521:
1436:
1396:
1381:
1351:
407:
through tizanidine capsule sales to promote dalfampridine sales.
375:
370:
In September 2014, the company acquired Civitas Therapeutics for
496:
2062:
1997:
1987:
1882:
1613:
1426:
1371:
864:"Acorda Buys Civitas and Its Phase III PD Candidate for $ 525M"
460:
319:
295:
131:
583:
communications) and Jane Wasman (president, international and
2077:
2047:
1982:
1471:
1401:
1386:
483:
for $ 70 million to reduce the company's operating expenses.
204:
1857:
1003:"Acorda (ACOR) Down More Than 60% in 3 Months: Here's Why"
1309:
386:
Acorda Therapeutics was incorporated in 1995, founded by
357:
rHIgM22, a remyelinating antibody for the treatment of
2163:
Companies that filed for Chapter 11 bankruptcy in 2024
957:"Drug researcher seeks spinal cord patients for trial"
2110:
1247:"Acorda Therapeutics Files for Bankruptcy Protection"
1000:
927:"Acorda Therapeutics Files for Bankruptcy Protection"
881:"Acorda Therapeutics to Acquire Civitas Therapeutics"
559:
As of February 14, 2019, the members of the
1130:"Acorda Discontinues Tozadenant Development Program"
1112:"Acorda Acquires Biotie Therapies for $ 363 Million"
727:"Acorda Therapeutics 2020 Annual Report (Form 10-K)"
467:
indication facing competition in the United States.
264:
1203:"Increasing Diversity Among Leadership And Boards"
2134:
2183:Health care companies based in New York (state)
2168:Companies based in Westchester County, New York
866:. Genetic Engineering & Biotechnology News.
821:"CVT-427 for the acute treatment of migraines"
687:
685:
683:
681:
679:
677:
2153:Pharmaceutical companies of the United States
1353:Pharmaceutical companies of the United States
1337:
675:
673:
671:
669:
667:
665:
663:
661:
659:
657:
631:
629:
627:
535:. This gave the company control over Biote's
515:through 2021, while the tablet form has many
381:
330:. Inbrija is approved by the FDA and the EU.
2148:Biotechnology companies of the United States
1741:
1116:Genetic Engineering & Biotechnology News
967:
475:In December 2018, the company announced the
2158:Biotechnology companies established in 1995
1156:"Parkinson's Tozadenant Trial Discontinued"
1118:. New Rochelle, New York: Mary Ann Liebert.
1001:Zacks Equity Research (September 3, 2019).
883:(Press release). Acorda. September 24, 2014
1344:
1330:
1314:
1263:
1136:(Press release). Acorda. November 20, 2017
1064:Kuhl, Maggie McGuire (December 26, 2018).
1046:(Press release). Acorda. December 21, 2018
654:
624:
374:, gaining the Phase III Parkinson's drug,
25:
189:
167:
1244:
1221:"Acorda Therapeutics Company Leadership"
1177:"Acorda Therapeutics Board of Directors"
954:
2178:1995 establishments in New York (state)
2143:Companies formerly listed on the Nasdaq
738:U.S. Securities and Exchange Commission
691:
554:
333:
2135:
1200:
1153:
1325:
1264:Kansteiner, Fraiser (July 11, 2024).
1109:
1019:
973:
950:
948:
875:
873:
861:
721:
719:
717:
715:
713:
711:
692:Alterio, Julie Moran (June 4, 2007).
449:Canadian Spinal Research Organization
1154:Dolhun, Rachel (November 15, 2017).
1063:
955:Rendline, Paul (January 27, 2003).
499:in the early 2000s to help meeting
365:
13:
1631:Pharmaceutical Product Development
945:
870:
708:
400:Columbia University Medical Center
14:
2194:
1301:
974:Court, Emma (November 21, 2016).
776:"Inbrija Prescribing Information"
390:turned entrepreneur Ron Cohen in
2120:
2100:List of pharmaceutical companies
752:"Ampyra Prescribing Information"
442:
233:
232:
211:
210:
188:
166:
145:
144:
1257:
1245:Glickman, Ben (April 1, 2024).
1238:
1213:
1194:
1169:
1147:
1122:
1103:
1079:
1057:
1032:
1013:
994:
919:
894:
855:
834:
813:
792:
768:
744:
537:primary sclerosing cholangitis
435:In 2024, the company declared
341:primary sclerosing cholangitis
282:company based in Pearl River,
16:American biotechnology company
1:
1507:Institute for OneWorld Health
617:
522:
486:
350:) for the acute treatment of
1726:West Pharmaceutical Services
862:Staff (September 24, 2014).
7:
1201:Wright, Rob (1 July 2019).
1020:Staff (September 5, 2019).
539:drug, BTT1023 and the oral
305:
70:; 29 years ago
10:
2199:
1532:McNeil Consumer Healthcare
1289:: CS1 maint: url-status (
1110:Staff (January 19, 2016).
503:goals. Acorda sells both
470:
382:History and business model
320:levodopa inhalation powder
296:levodopa inhalation powder
2095:
2038:Smith, Kline & French
1850:
1734:
1589:Northwest Biotherapeutics
1574:Merrimack Pharmaceuticals
1359:
982:. Dow Jones & Company
455:in patients with chronic
276:Acorda Therapeutics, Inc.
259:
246:
224:
202:
180:
158:
140:
119:
105:
94:420 Saw Mill River Road,
90:
82:
64:
43:
33:
24:
20:Acorda Therapeutics, Inc.
580:chief scientific officer
339:BTT1023 (timolumab) for
302:) in the United States.
931:The Wall Street Journal
694:"In pursuit of MS drug"
597:chief operating officer
593:chief financial officer
572:chief executive officer
412:initial public offering
2173:Life sciences industry
1963:Leiner Health Products
1407:Amneal Pharmaceuticals
703:Second page of article
541:adenosine A2A receptor
1517:Johnson & Johnson
1227:. Acorda Therapeutics
1183:. Acorda Therapeutics
578:), Andrew R. Blight (
576:chief medical officer
491:The company licensed
437:Chapter 11 bankruptcy
414:(IPO) in 2006 raised
1811:Jazz Pharmaceuticals
1801:Horizon Therapeutics
1671:Sarepta Therapeutics
1646:Proteon Therapeutics
1641:Procter & Gamble
1554:Melinta Therapeutics
1447:Bristol Myers Squibb
1028:. Sydney, Australia.
740:. February 20, 2020.
604:stalking horse offer
595:and Mary Fisher the
555:Corporate governance
334:Development pipeline
194:US$ −272.966 million
172:US$ −311.632 million
2018:Repros Therapeutics
1933:Forest Laboratories
1918:Cutter Laboratories
1636:Prasco Laboratories
1377:Acorda Therapeutics
1367:Abbott Laboratories
1251:Wall Street Journal
1207:Life Science Leader
574:), Burkhard Blank (
545:Parkinson's disease
392:Hawthorne, New York
288:Parkinson's disease
248:Number of employees
238:US$ 310.820 million
216:US$ 799.718 million
150:US$ 192.408 million
21:
1978:Miles Laboratories
1968:Martek Biosciences
1791:Endo International
1711:Ventria Bioscience
1477:Danco Laboratories
641:Investor Resources
612:Merz Therapeutics
561:board of directors
465:multiple sclerosis
457:spinal cord injury
359:multiple sclerosis
328:carbidopa/levodopa
292:multiple sclerosis
19:
2108:
2107:
2091:
2090:
1923:DNAPrint Genomics
1412:Avax Technologies
734:www.ir.acorda.com
513:patent protection
273:
272:
255:
242:
220:
198:
176:
154:
96:Ardsley, New York
2190:
2125:
2124:
2123:
2116:
1739:
1738:
1686:Tec Laboratories
1559:Melior Discovery
1544:Kinetic Concepts
1487:Galena Biopharma
1346:
1339:
1332:
1323:
1322:
1318:
1313:
1312:
1310:Official website
1295:
1294:
1288:
1280:
1278:
1276:
1261:
1255:
1254:
1242:
1236:
1235:
1233:
1232:
1217:
1211:
1210:
1198:
1192:
1191:
1189:
1188:
1173:
1167:
1166:
1164:
1163:
1151:
1145:
1144:
1142:
1141:
1126:
1120:
1119:
1107:
1101:
1100:
1098:
1097:
1083:
1077:
1076:
1074:
1073:
1061:
1055:
1054:
1052:
1051:
1036:
1030:
1029:
1017:
1011:
1010:
998:
992:
991:
989:
987:
971:
965:
964:
952:
943:
942:
940:
938:
923:
917:
916:
914:
913:
898:
892:
891:
889:
888:
877:
868:
867:
859:
853:
852:
850:
849:
838:
832:
831:
829:
828:
817:
811:
810:
808:
807:
796:
790:
789:
787:
785:
780:
772:
766:
765:
763:
761:
756:
748:
742:
741:
731:
723:
706:
701:
698:The Journal News
689:
652:
651:
649:
648:
633:
534:
529:Biotie Therapies
495:(Zanaflex) from
421:
420:US$ 29.8 million
417:
416:US$ 31.5 million
373:
366:ARCUS Technology
269:
266:
253:
240:
239:
236:
235:
229:
218:
217:
214:
213:
207:
196:
195:
192:
191:
174:
173:
170:
169:
161:Operating income
152:
151:
148:
147:
78:
76:
71:
29:
22:
18:
2198:
2197:
2193:
2192:
2191:
2189:
2188:
2187:
2133:
2132:
2131:
2121:
2119:
2111:
2109:
2104:
2087:
2033:Schering-Plough
1943:ImClone Systems
1846:
1730:
1579:Myriad Genetics
1569:Merck & Co.
1527:Janssen Biotech
1497:Gilead Sciences
1355:
1350:
1308:
1307:
1304:
1299:
1298:
1282:
1281:
1274:
1272:
1262:
1258:
1243:
1239:
1230:
1228:
1219:
1218:
1214:
1199:
1195:
1186:
1184:
1175:
1174:
1170:
1161:
1159:
1152:
1148:
1139:
1137:
1128:
1127:
1123:
1108:
1104:
1095:
1093:
1085:
1084:
1080:
1071:
1069:
1062:
1058:
1049:
1047:
1038:
1037:
1033:
1018:
1014:
999:
995:
985:
983:
972:
968:
961:The Daily Times
953:
946:
936:
934:
933:. April 1, 2024
925:
924:
920:
911:
909:
900:
899:
895:
886:
884:
879:
878:
871:
860:
856:
847:
845:
840:
839:
835:
826:
824:
819:
818:
814:
805:
803:
798:
797:
793:
783:
781:
778:
774:
773:
769:
759:
757:
754:
750:
749:
745:
729:
725:
724:
709:
690:
655:
646:
644:
635:
634:
625:
620:
585:general counsel
557:
549:agranulocytosis
533:US$ 363 million
532:
525:
489:
473:
445:
427:turned a profit
419:
415:
384:
372:US$ 525 million
371:
368:
336:
308:
278:is an American
263:
249:
237:
225:
215:
203:
193:
185:
171:
163:
149:
136:
108:
101:
74:
72:
69:
60:
17:
12:
11:
5:
2196:
2186:
2185:
2180:
2175:
2170:
2165:
2160:
2155:
2150:
2145:
2130:
2129:
2106:
2105:
2103:
2102:
2096:
2093:
2092:
2089:
2088:
2086:
2085:
2080:
2075:
2070:
2065:
2060:
2055:
2050:
2045:
2040:
2035:
2030:
2025:
2020:
2015:
2010:
2005:
2000:
1995:
1990:
1985:
1980:
1975:
1970:
1965:
1960:
1955:
1950:
1945:
1940:
1935:
1930:
1925:
1920:
1915:
1910:
1905:
1900:
1895:
1890:
1885:
1880:
1875:
1870:
1865:
1863:Allergan, Inc.
1860:
1854:
1852:
1848:
1847:
1845:
1844:
1843:(Canada, 2010)
1838:
1828:
1818:
1808:
1798:
1788:
1778:
1768:
1758:
1747:
1745:
1736:
1732:
1731:
1729:
1728:
1723:
1718:
1713:
1708:
1703:
1698:
1693:
1688:
1683:
1678:
1673:
1668:
1663:
1658:
1653:
1648:
1643:
1638:
1633:
1628:
1627:
1626:
1621:
1611:
1606:
1601:
1596:
1594:Norwich Pharma
1591:
1586:
1581:
1576:
1571:
1566:
1561:
1556:
1551:
1546:
1541:
1540:
1539:
1534:
1529:
1524:
1514:
1509:
1504:
1499:
1494:
1489:
1484:
1479:
1474:
1469:
1464:
1459:
1454:
1449:
1444:
1439:
1434:
1429:
1424:
1419:
1414:
1409:
1404:
1399:
1394:
1389:
1384:
1379:
1374:
1369:
1363:
1361:
1357:
1356:
1349:
1348:
1341:
1334:
1326:
1320:
1319:
1303:
1302:External links
1300:
1297:
1296:
1256:
1237:
1212:
1209:. VertMarkets.
1193:
1168:
1146:
1121:
1102:
1091:Endpoints News
1078:
1056:
1031:
1026:Simply Wall St
1012:
1007:Yahoo! Finance
993:
966:
944:
918:
893:
869:
854:
833:
812:
791:
767:
743:
707:
653:
622:
621:
619:
616:
556:
553:
524:
521:
488:
485:
472:
469:
444:
441:
404:business model
383:
380:
367:
364:
363:
362:
355:
344:
335:
332:
324:
323:
316:
307:
304:
300:(dalfampridine
271:
270:
261:
257:
256:
250:
247:
244:
243:
230:
222:
221:
208:
200:
199:
186:
181:
178:
177:
164:
159:
156:
155:
142:
138:
137:
135:
134:
129:
123:
121:
117:
116:
109:
106:
103:
102:
99:
92:
88:
87:
84:
80:
79:
66:
62:
61:
59:
58:
53:
47:
45:
41:
40:
35:
31:
30:
15:
9:
6:
4:
3:
2:
2195:
2184:
2181:
2179:
2176:
2174:
2171:
2169:
2166:
2164:
2161:
2159:
2156:
2154:
2151:
2149:
2146:
2144:
2141:
2140:
2138:
2128:
2118:
2117:
2114:
2101:
2098:
2097:
2094:
2084:
2081:
2079:
2076:
2074:
2071:
2069:
2066:
2064:
2061:
2059:
2056:
2054:
2051:
2049:
2046:
2044:
2043:Sterling Drug
2041:
2039:
2036:
2034:
2031:
2029:
2026:
2024:
2021:
2019:
2016:
2014:
2011:
2009:
2006:
2004:
2001:
1999:
1996:
1994:
1991:
1989:
1986:
1984:
1981:
1979:
1976:
1974:
1971:
1969:
1966:
1964:
1961:
1959:
1956:
1954:
1951:
1949:
1946:
1944:
1941:
1939:
1936:
1934:
1931:
1929:
1926:
1924:
1921:
1919:
1916:
1914:
1911:
1909:
1906:
1904:
1901:
1899:
1896:
1894:
1891:
1889:
1886:
1884:
1881:
1879:
1876:
1874:
1871:
1869:
1866:
1864:
1861:
1859:
1856:
1855:
1853:
1849:
1842:
1841:Bausch Health
1839:
1836:
1832:
1829:
1826:
1822:
1819:
1816:
1812:
1809:
1806:
1802:
1799:
1796:
1792:
1789:
1786:
1782:
1779:
1776:
1772:
1769:
1766:
1762:
1759:
1756:
1752:
1749:
1748:
1746:
1744:
1743:Tax inversion
1740:
1737:
1733:
1727:
1724:
1722:
1719:
1717:
1714:
1712:
1709:
1707:
1704:
1702:
1699:
1697:
1694:
1692:
1689:
1687:
1684:
1682:
1679:
1677:
1674:
1672:
1669:
1667:
1664:
1662:
1659:
1657:
1654:
1652:
1651:Purdue Pharma
1649:
1647:
1644:
1642:
1639:
1637:
1634:
1632:
1629:
1625:
1622:
1620:
1617:
1616:
1615:
1612:
1610:
1607:
1605:
1602:
1600:
1597:
1595:
1592:
1590:
1587:
1585:
1582:
1580:
1577:
1575:
1572:
1570:
1567:
1565:
1562:
1560:
1557:
1555:
1552:
1550:
1547:
1545:
1542:
1538:
1535:
1533:
1530:
1528:
1525:
1523:
1520:
1519:
1518:
1515:
1513:
1510:
1508:
1505:
1503:
1500:
1498:
1495:
1493:
1490:
1488:
1485:
1483:
1480:
1478:
1475:
1473:
1470:
1468:
1465:
1463:
1460:
1458:
1455:
1453:
1450:
1448:
1445:
1443:
1440:
1438:
1435:
1433:
1430:
1428:
1425:
1423:
1420:
1418:
1415:
1413:
1410:
1408:
1405:
1403:
1400:
1398:
1395:
1393:
1390:
1388:
1385:
1383:
1380:
1378:
1375:
1373:
1370:
1368:
1365:
1364:
1362:
1358:
1354:
1347:
1342:
1340:
1335:
1333:
1328:
1327:
1324:
1317:
1311:
1306:
1305:
1292:
1286:
1275:September 25,
1271:
1270:Fierce Pharma
1267:
1260:
1252:
1248:
1241:
1226:
1222:
1216:
1208:
1204:
1197:
1182:
1178:
1172:
1157:
1150:
1135:
1134:Investor News
1131:
1125:
1117:
1113:
1106:
1092:
1088:
1082:
1067:
1060:
1045:
1044:Investor News
1041:
1035:
1027:
1023:
1016:
1008:
1004:
997:
981:
977:
970:
962:
958:
951:
949:
932:
928:
922:
908:. 26 May 2021
907:
906:simplywall.st
903:
897:
882:
876:
874:
865:
858:
843:
837:
822:
816:
801:
795:
777:
771:
753:
747:
739:
735:
728:
722:
720:
718:
716:
714:
712:
704:
699:
695:
688:
686:
684:
682:
680:
678:
676:
674:
672:
670:
668:
666:
664:
662:
660:
658:
642:
638:
632:
630:
628:
623:
615:
613:
609:
605:
600:
598:
594:
588:
586:
581:
577:
573:
569:
564:
562:
552:
550:
546:
542:
538:
530:
520:
519:competitors.
518:
514:
510:
506:
502:
498:
494:
484:
482:
478:
468:
466:
462:
458:
454:
450:
443:Dalfampridine
440:
438:
433:
430:
428:
423:
413:
408:
405:
401:
397:
393:
389:
379:
377:
360:
356:
353:
349:
345:
342:
338:
337:
331:
329:
321:
317:
314:
313:dalfampridine
310:
309:
303:
301:
298:) and Ampyra
297:
293:
289:
285:
281:
280:biotechnology
277:
268:
262:
258:
251:
245:
231:
228:
223:
209:
206:
201:
187:
184:
179:
165:
162:
157:
143:
139:
133:
130:
128:
125:
124:
122:
118:
114:
110:
104:
100:United States
97:
93:
89:
85:
81:
67:
63:
57:
56:Biotechnology
54:
52:
49:
48:
46:
42:
39:
36:
32:
28:
23:
1821:Mallinckrodt
1706:Upsher-Smith
1537:Ortho-McNeil
1376:
1273:. Retrieved
1269:
1259:
1250:
1240:
1229:. Retrieved
1225:About Acorda
1224:
1215:
1206:
1196:
1185:. Retrieved
1181:About Acorda
1180:
1171:
1160:. Retrieved
1149:
1138:. Retrieved
1133:
1124:
1115:
1105:
1094:. Retrieved
1090:
1081:
1070:. Retrieved
1059:
1048:. Retrieved
1043:
1034:
1025:
1015:
1006:
996:
984:. Retrieved
979:
969:
960:
935:. Retrieved
930:
921:
910:. Retrieved
905:
896:
885:. Retrieved
857:
846:. Retrieved
836:
825:. Retrieved
815:
804:. Retrieved
794:
784:February 14,
782:. Retrieved
770:
760:February 14,
758:. Retrieved
746:
733:
697:
645:. Retrieved
640:
601:
589:
565:
558:
526:
490:
474:
446:
434:
431:
424:
409:
385:
369:
348:zolmitriptan
325:
275:
274:
227:Total equity
205:Total assets
91:Headquarters
34:Company type
2013:Parke-Davis
1696:Trevena Inc
1564:Mentholatum
1372:AbbVie Inc.
986:16 December
980:MarketWatch
610:subsidiary
608:Merz Pharma
396:neurologist
111:Ron Cohen (
51:Health care
2137:Categories
2073:ViroPharma
1973:Massengill
1701:Ultragenyx
1432:Bioverativ
1231:2019-02-14
1187:2019-02-14
1162:2019-02-14
1140:2019-09-24
1096:2021-03-05
1072:2019-02-14
1050:2019-09-24
912:2021-06-16
887:2019-09-24
848:2019-02-14
827:2019-09-24
806:2019-09-24
647:2019-09-24
618:References
523:Tozadenant
493:tizanidine
487:Tizanidine
453:spasticity
343:(phase II)
183:Net income
107:Key people
86:Ron Cohen
2127:Companies
2023:Qualitest
1893:CancerVax
1676:Sheffield
1666:RespireRx
1661:Regeneron
1512:Intercept
1492:Genentech
1482:Eli Lilly
1467:CytoSport
1457:Ceragenix
800:"BTT1023"
568:president
501:cash flow
388:internist
361:(phase I)
354:(phase I)
346:CVT-427 (
318:Inbrija (
1903:CoTherix
1898:Cephalon
1781:Covidien
1771:Allergan
1761:Alkermes
1681:Spectrum
1549:McKesson
1442:Biovista
1422:BioCryst
1285:cite web
937:April 1,
844:. Acorda
823:. Acorda
802:. Acorda
643:. Acorda
481:Catalent
352:migraine
311:Ampyra (
306:Products
284:New York
120:Products
44:Industry
2058:Trubion
1908:Covance
1888:Bradley
1837:, 2013)
1835:Ireland
1831:Perrigo
1827:, 2013)
1825:Ireland
1817:, 2012)
1815:Ireland
1807:, 2014)
1805:Ireland
1797:, 2014)
1795:Ireland
1787:, 2007)
1785:Ireland
1777:, 2015)
1775:Ireland
1767:, 2011)
1765:Ireland
1757:, 2013)
1755:Ireland
1751:Actavis
1721:Viatris
1619:Hospira
1609:Ovation
1604:Organon
1599:NovaBay
1584:Moderna
1522:Ethicon
1452:Century
1437:Biovest
1397:Alnylam
1392:Alexion
1382:Advaxis
1360:Current
517:generic
505:capsule
471:Inbrija
402:. The
376:CVT-301
260:Website
141:Revenue
132:Inbrija
83:Founder
73: (
65:Founded
2113:Portal
2083:Zonite
2063:Upjohn
1998:Nuvelo
1993:Nereus
1988:Naurex
1913:Cubist
1883:Biolex
1868:Amylin
1735:Former
1716:Vertex
1624:Searle
1614:Pfizer
1427:Biogen
1417:Baxter
637:"FAQs"
531:, for
509:tablet
461:stroke
265:acorda
254:(2020)
241:(2019)
219:(2019)
197:(2019)
175:(2019)
153:(2019)
127:Ampyra
38:Public
2078:Wyeth
2068:Verus
2048:Tanox
2028:Rib-X
2003:Ortho
1983:Mylan
1938:Genta
1873:ARIAD
1851:Other
1691:Titan
1656:Quark
1502:Ionis
1472:CytRx
1462:Combe
1402:Amgen
1387:Alcon
779:(PDF)
755:(PDF)
730:(PDF)
606:from
1953:King
1948:ISTA
1928:Epix
1878:Barr
1858:Alza
1291:link
1277:2024
988:2016
939:2024
786:2019
762:2019
570:and
507:and
497:Élan
447:The
267:.com
252:344
75:1995
68:1995
2053:TAP
2008:OSI
587:).
477:FDA
410:An
398:at
113:CEO
2139::
1958:KV
1287:}}
1283:{{
1268:.
1249:.
1223:.
1205:.
1179:.
1132:.
1114:.
1089:.
1042:.
1024:.
1005:.
978:.
959:.
947:^
929:.
904:.
872:^
736:.
732:.
710:^
696:.
656:^
639:.
626:^
429:.
422:.
290:,
98:,
2115::
1833:(
1823:(
1813:(
1803:(
1793:(
1783:(
1773:(
1763:(
1753:(
1345:e
1338:t
1331:v
1293:)
1279:.
1253:.
1234:.
1190:.
1165:.
1143:.
1099:.
1075:.
1053:.
1009:.
990:.
941:.
915:.
890:.
851:.
830:.
809:.
788:.
764:.
705:.
650:.
322:)
315:)
115:)
77:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
